Header

UZH-Logo

Maintenance Infos

Publications for Alber, H

Navigate back| Up a level
Export as
Group by:
Jump to:
Number of items: 3.

2015

Kaiser, Christoph; Galatius, Soeren; Jeger, Raban; Gilgen, Nicole; Jensen, Jan Skov; Naber, Christoph; Alber, Hannes; Wanitschek, Maria; Eberli, Franz; Kurz, David J; Pedrazzini, Giovanni; Moccetti, Tiziano; Rickli, Hans; Weilenmann, Daniel; Vuillomenet, André; Steiner, Martin; Felten, Stefanie Von; Vogt, Deborah R; Hansen, Kim Wadt; Rickenbacher, Peter; Conen, David; Müller, Christian; Buser, Peter; Hoffmann, Andreas; Pfisterer, Matthias (2015). Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents: Main Results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), A Randomized, Controlled Noninferiority 2-Year Outcome Trial. Circulation, 131(1):74-81.

2014

Jeger, Raban V; Pfisterer, Matthias E; Sørensen, Rikke; von Felten, Stefanie; Alber, Hannes; Bonetti, Piero O; Eberli, Franz; Erne, Paul; Pedrazzini, Giovanni; Rickli, Hans; Galatius, Søren; Kaiser, Christoph A (2014). Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. American Heart Journal, 168(5):698-705.

2012

Jeger, Raban; Pfisterer, Matthias; Alber, Hannes; Eberli, Franz; Galatius, Søren; Naber, Christoph; Pedrazzini, Giovanni; Rickli, Hans; Jensen, Jan Skov; Vuilliomenet, André; Gilgen, Nicole; Kaiser, Christoph (2012). Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design. American Heart Journal, 163(2):136-141.e1.

This list was generated on Sat Dec 16 10:50:09 2017 CET.